跳至主要内容
临床试验/NCT02878707
NCT02878707已完成不适用

The Neuroprotective Effects of Dexmedetomidine During Brain Surgery

National Taiwan University Hospital1 个研究点 分布在 1 个国家目标入组 160 人开始时间: 2017年4月24日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
160
试验地点
1
主要终点
Number of participants with postoperative neurological complications

研究概览

简要总结

Dexmedetomidine (DEX) is a Alpha-2 specific agonist, is a common ICU sedation medication. In brain tumor resection craniotomy, it is proven to be effective in improving postoperative hypertension and tachycardia, mitigates postoperative nausea and vomiting and relives postoperative pain. In addition, many animal experiments show that DEX inhibits the proapoptosis in the mitochondrial in vivo and therefore avoids neuronal injury. It is also reported to be neuroprotective to isoflurane-induced neurotoxicity and to improve cerebral focal ischemic region (penumbra). However, the neuroprotective effects were never investigated clinically in patients undergoing brain tumor resection surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients undergoing elective craniotomy for supratentorial brain tumor resection or cerebral vascular surgery
  • age between 20 to 80 yr

排除标准

  • Fever, elevated white blood cell or C-reactive protein
  • Impaired liver function, eg. AST or ALT >100; liver cirrhosis > Child B class
  • Impaired renal function, cGFR< 60 ml/min/1.73 m2
  • Cardiac dysfunction, such as heart failure > NYHA class II

研究组 & 干预措施

DEX

Experimental

Intraoperative intravenous infusion of dexmedetomidine

干预措施: Dexmedetomidine (Drug)

Control

Placebo Comparator

Intraoperative intravenous infusion of 0.9% saline

干预措施: Dexmedetomidine (Drug)

结局指标

主要结局

Number of participants with postoperative neurological complications

时间窗: during postoperative period of hospital admission, approximately 10 days by estimation

次要结局

  • Number of participants with postoperative delirium(during postoperative period of hospital admission, approximately 10 days by estimation)
  • Serum biomarkers changes(Between preoperative baseline and postoperative day one.)
  • Intraoperative haemodynamic profile(during intraoperative perioid, approximately 4-6 hours by estimation)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验